UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.120

Sortiert nach

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Clinical Microbiology Reviews, 2007-01, Vol.20 (1), p.133-163

2007

Volltextzugriff (PDF)

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Journal of Clinical Microbiology, 2012-09, Vol.50 (9), p.2846-2856

2012

Volltextzugriff (PDF)

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

Journal of Clinical Microbiology, 2012-04, Vol.50 (4), p.1199-1203

2012

Volltextzugriff (PDF)

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2497-2506

2010

Volltextzugriff (PDF)

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

Journal of Clinical Microbiology, 2008-01, Vol.46 (1), p.150-156

2008

Volltextzugriff (PDF)

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Journal of Clinical Microbiology, 2010-04, Vol.48 (4), p.1366-1377

2010

Volltextzugriff (PDF)

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Journal of Clinical Microbiology, 2010-09, Vol.48 (9), p.3251-3257

2010

Volltextzugriff (PDF)

In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017

Antimicrobial agents and chemotherapy, 2019-08, Vol.63 (8)

2019

Volltextzugriff (PDF)

Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus

Journal of clinical microbiology, 2004-10, Vol.42 (10), p.4419-4431

2004

Volltextzugriff (PDF)

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.5836-5842

2013

Volltextzugriff (PDF)

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.760-763

2006

Volltextzugriff (PDF)

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

Antimicrobial agents and chemotherapy, 2017-04, Vol.61 (4)

2017

Volltextzugriff (PDF)

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

Journal of Clinical Microbiology, 2012-06, Vol.50 (6), p.2040-2046

2012

Volltextzugriff (PDF)

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp

Journal of Clinical Microbiology, 2010-01, Vol.48 (1), p.52-56

2010

Volltextzugriff (PDF)

Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

Clinical Microbiology Reviews, 2006-04, Vol.19 (2), p.435-447

2006

Volltextzugriff (PDF)

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5150-5154

2011

Volltextzugriff (PDF)

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Journal of Clinical Microbiology, 2009-01, Vol.47 (1), p.117-123

2009

Volltextzugriff (PDF)

Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens

Journal of Clinical Microbiology, 2009-12, Vol.47 (12), p.3797-3804

2009

Volltextzugriff (PDF)

International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method

Antimicrobial agents and chemotherapy, 2016-02, Vol.60 (2), p.1079-1084

2016

Volltextzugriff (PDF)

In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods

Journal of Clinical Microbiology, 2009-10, Vol.47 (10), p.3170-3177

2009

Volltextzugriff (PDF)

Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole

Antimicrobial agents and chemotherapy, 2014-04, Vol.58 (4), p.2006-2012

2014

Volltextzugriff (PDF)

In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model

Antimicrobial Agents and Chemotherapy, 2008-10, Vol.52 (10), p.3497-3503

2008

Volltextzugriff (PDF)

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Volltextzugriff (PDF)

Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method

Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.3823-3828

2013

Volltextzugriff (PDF)

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

Journal of Clinical Microbiology, 2009-10, Vol.47 (10), p.3185-3190

2009

Volltextzugriff (PDF)

1 – 25 von 1.120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.013)
Mit Volltextzugriff
(1.023)

Publikationsform

Sprache

Englisch
(1.071)
Japanisch
(132)
Deutsch
(47)
Russisch
(4)
Spanisch
(1)
Portugiesisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(773)
Life Sciences & Biomedicine
(757)
Humans
(618)
Biological And Medical Sciences
(596)
Microbiology
(580)
Medical Sciences
(447)
Infectious Diseases
(399)
Microbial Sensitivity Tests
(299)
Pharmacology. Drug Treatments
(270)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(262)
Fundamental And Applied Biological Sciences. Psychology
(260)
Antifungal Agents - Pharmacology
(225)
Mycology
(182)
Candida - Drug Effects
(166)
Antibacterial Agents
(138)
Pharmacology & Pharmacy
(127)
Anti-Bacterial Agents - Pharmacology
(125)
Antifungal Agents
(123)
Microbial Sensitivity Tests - Methods
(119)
Candida
(112)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017

Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp

Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens

International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method

In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods

Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole

In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values

Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

Suchergebnisse filtern